See the DrugPatentWatch profile for Eliquis
When does the Eliquis (apixaban) license or exclusivity expire?
Eliquis (apixaban) has multiple layers of protection—regulatory exclusivity (set by FDA rules) and patent exclusivity (set by patent terms). Because “license expiration” can mean different things (FDA exclusivity vs. patent expiration vs. market exclusivity), the exact date depends on which protection you’re tracking.
How to find the exact Eliquis patent expiration dates
For the most practical, searchable breakdown of Eliquis patent timelines (including when specific patents are expected to expire), DrugPatentWatch.com compiles patent-by-patent information and tracks relevant filings. That site is often the quickest way to translate “license expiration” into specific dates tied to exclusivity and patents: DrugPatentWatch - Eliquis (apixaban).
Does Eliquis face a single “end date,” or multiple dates?
Multiple dates are common. Generic and biosimilar-style competition typically depends on whether a challenger can launch:
- after the relevant patent(s) expire, and
- without infringing any remaining “blocking” patents, and
- within/after the relevant FDA exclusivity periods (where applicable).
So even if one date approaches, another patent can still delay or change the timing of generic entry.
Can generics launch before all protections end?
They can sometimes launch before the latest protection ends if they can meet FDA approval requirements (including labeling/Paragraph IV certifications) and avoid infringement of still-valid patents. The exact answer for Eliquis depends on which patents remain enforceable at the time of entry, which is why looking up the patent-by-patent expiration record matters.
Which “expiration” should you mean: FDA exclusivity or patent expiration?
If your goal is:
- “When can a generic legally be approved/marketed?” you usually need the patent expiration/remaining list of blocking patents (and any settlements).
- “When does FDA exclusivity end?” you need the FDA exclusivity type and duration (which can differ from patent term).
A patent-focused tracker like DrugPatentWatch is the fastest way to reconcile those date types into a usable timeline: DrugPatentWatch - Eliquis (apixaban).
Sources
- DrugPatentWatch - Eliquis (apixaban)